PreciseDx
Latest round
- Series A
Last raised
- May 2025
Total raised
- $43M
Investors
- 10
About PreciseDx
Based in New York, US, and founded in 2020 by CTO Jack Zeineh, CSO Gerardo Fernandez, CMO Michael Donovan, and Chairman of the Advisory Board Carlos Cordon-Cardo. PreciseDx offers Morphology Feature ArrayTM, a personalized medicine based on artificial intelligence that provides patient-specific risk information based on morphology feature analysis. It combines critical tissue-derived information with clinical data. The company's platform enables individualized treatment plans and improved patient outcomes. The company's products include breast tests and prostate tests.
Who invested in PreciseDx
10 investors across 3 rounds
See all investors in PreciseDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PreciseDx
Who invested in PreciseDx?
PreciseDx has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PreciseDx raised?
PreciseDx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PreciseDx last raise money?
PreciseDx's most recent round on record is a Series A, in May 2025.
What does PreciseDx do?
Based in New York, US, and founded in 2020 by CTO Jack Zeineh, CSO Gerardo Fernandez, CMO Michael Donovan, and Chairman of the Advisory Board Carlos Cordon-Cardo.
Where is PreciseDx headquartered?
PreciseDx is headquartered in New York, US.
Which VCs invest in companies like PreciseDx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at PreciseDx's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like PreciseDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.